Skip Navigation
 

Funding


RCDC

Project Listing by Category


Back to Estimates of Funding for Various Research, Condition, and Disease Categories (RCDC) Click the column headings to sort project listings.
  Help
CategoryFYFunding ICProject NumberSub Project #Project TitlePI NameOrg NameState / CountryAmount
Mucopolysaccharidoses (MPS) 2010 NINDS 5R01NS029390-18 Gene Transfer To and Expression in Neurons In Vivo FRASER, NIGEL UNIVERSITY OF PENNSYLVANIA PA $413,811
Mucopolysaccharidoses (MPS) 2010 NIDDK 5R01DK066448-07 RETROVIRAL VECTOR-MEDIATED LIVER GENE THERAPY FOR MPS I PONDER, KATHERINE WASHINGTON UNIVERSITY MO $365,072
Mucopolysaccharidoses (MPS) 2010 NINDS 5R01NS057412-04 Suppression of the Idua-W402X mutation in an MPS I-H mouse BEDWELL, DAVID UNIVERSITY OF ALABAMA AT BIRMINGHAM AL $314,016
Mucopolysaccharidoses (MPS) 2010 NIDDK 1K08DK085141-01 Transplacental stem cell transplantation and evaluation of therapeutic effect HELDERMON, COY UNIVERSITY OF FLORIDA FL $146,167
Mucopolysaccharidoses (MPS) 2010 NIDDK 5R01DK054481-15 Gene Therapy of Mucopolysaccharidosis VII HASKINS, MARK UNIVERSITY OF PENNSYLVANIA PA $501,777
Mucopolysaccharidoses (MPS) 2010 NCRR 5P40RR002512-26 Referral Center - Animal models of human genetic disease HASKINS, MARK UNIVERSITY OF PENNSYLVANIA PA $720,683
Mucopolysaccharidoses (MPS) 2010 NINDS 5R01NS038690-09 AAV Gene Therapy for the CNS in MPS VII WOLFE, JOHN CHILDRENS HOSPITAL OF PHILADELPHIA PA $468,927
Mucopolysaccharidoses (MPS) 2010 NIDDK 1R41DK085944-01 Lentiviral gene therapy for mucopolysaccharidosis MCIVOR, R LENTIGEN CORPORATION MD $364,844
Mucopolysaccharidoses (MPS) 2010 NCI 5R01CA098468-07 Improving CPT-11 Efficacy Using Structural and Chemical Biology REDINBO, MATTHEW UNIVERSITY OF NORTH CAROLINA CHAPEL HILL NC $262,200
Mucopolysaccharidoses (MPS) 2010 NINDS 5R01NS022376-23 Molecular Studies of Sanfilippo Syndrome Type B NEUFELD, ELIZABETH UNIVERSITY OF CALIFORNIA LOS ANGELES CA $333,507
Mucopolysaccharidoses (MPS) 2010 NINDS 5R01NS054242-05 Intrathecal enzyme therapy for mucopolysaccharidosis I DICKSON, PATRICIA LA BIOMED RES INST/ HARBOR UCLA MED CTR CA $350,323
Mucopolysaccharidoses (MPS) 2010 NIDDK 5R01DK067859-11 Multiplex Analysis of Inborn Errors of Metabolism TURECEK, FRANTISEK UNIVERSITY OF WASHINGTON WA $286,376
Mucopolysaccharidoses (MPS) 2010 NINDS 5U44NS064602-02 Iduronidase Replacement Therapy of the Brain in Hurler's Syndrome BOADO, RUBEN ARMAGEN TECHNOLOGIES, INC. CA $982,874
Mucopolysaccharidoses (MPS) 2010 NINDS 5R01NS056243-04 Stem Cell Transplantation for Neurogenetic Disease WOLFE, JOHN CHILDRENS HOSPITAL OF PHILADELPHIA PA $352,600
Mucopolysaccharidoses (MPS) 2010 NINDS 1R01NS061809-01A1 Gene therapy for alpha-mannosidosis HASKINS, MARK UNIVERSITY OF PENNSYLVANIA PA $199,375
Mucopolysaccharidoses (MPS) 2010 NIDDK 5R01DK087185-02 Novel Therapies and Biomarkers for the Mucopolysaccharidoses SIMONARO, CALOGERA MOUNT SINAI SCHOOL OF MEDICINE NY $402,732
Mucopolysaccharidoses (MPS) 2010 NIDDK 1R01DK082516-01A2 SB Transposons for Gene Therapy HACKETT, PERRY UNIVERSITY OF MINNESOTA TWIN CITIES MN $367,204
Mucopolysaccharidoses (MPS) 2010 NIGMS 2R01GM034182-23A1 Receptor-mediated transport of lysosomal enzymes SLY, WILLIAM SAINT LOUIS UNIVERSITY MO $368,750
Mucopolysaccharidoses (MPS) 2010 NINDS 5R01NS064330-03 Genetic Therapy for CNS Manifestations in MPS I via BBB-targeted Protein Delivery PAN, DAO CHILDREN'S HOSPITAL MED CTR (CINCINNATI) OH $324,845
Mucopolysaccharidoses (MPS) 2010 NIAMS 1K23AR057789-01A1 Natural history of bone disease and the impact of growth hormone treatment in MPS POLGREEN, LYNDA UNIVERSITY OF MINNESOTA TWIN CITIES MN $129,830
Mucopolysaccharidoses (MPS) 2010 NIDDK 1F32DK085905-01A1 Substrate Reduction Therapy Strategies for Treatment of Mucopolysaccharidoses LAMANNA, WILLIAM UNIVERSITY OF CALIFORNIA SAN DIEGO CA $50,474
Mucopolysaccharidoses (MPS) 2010 NINDS 1R43NS071774-01 Substrate Optimization Therapy: A Novel Therapy for Mucopolysaccharidosis CRAWFORD, BRETT ZACHARON PHARMACEUTICALS, INC. CA $339,513
Mucopolysaccharidoses (MPS) 2010 NIDDK 5U54NS065768-02 6493 Longitudinal Studies of Brain Structure and Function in MPS Disorder SHAPIRO, ELSA UNIVERSITY OF MINNESOTA TWIN CITIES MN $38,967
Mucopolysaccharidoses (MPS) 2010 NINDS 5U54NS065768-02 6493 Longitudinal Studies of Brain Structure and Function in MPS Disorder SHAPIRO, ELSA UNIVERSITY OF MINNESOTA TWIN CITIES MN $66,215
Mucopolysaccharidoses (MPS) 2010 OD 5U54NS065768-02 6493 Longitudinal Studies of Brain Structure and Function in MPS Disorder SHAPIRO, ELSA UNIVERSITY OF MINNESOTA TWIN CITIES MN $11,690
Mucopolysaccharidoses (MPS) 2010 NCRR 5P51RR013986-12 8584 ADENO ASSOCIATED VIRUS (AAV) GENE THERAPY FOR MUCOPOLYSACCHARIDOSIS TYPE II BRUNETTI-PIERRI, NICOLA SOUTHWEST FOUNDATION FOR BIOMEDICAL RES TX $14,490
Mucopolysaccharidoses (MPS) 2010 OD 5P51RR013986-12 8584 ADENO ASSOCIATED VIRUS (AAV) GENE THERAPY FOR MUCOPOLYSACCHARIDOSIS TYPE II BRUNETTI-PIERRI, NICOLA SOUTHWEST FOUNDATION FOR BIOMEDICAL RES TX $1,500


  • Download Readers:
  • Download Adobe PDF Reader
  • Download Microsoft PowerPoint Viewer
  • Download Microsoft Word Viewer
  • Download Microsoft Excel Viewer